Question 1

Does Citadel Advisors own RLMD stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 1,061,665 shares of RLMD (Relmada Therapeutics), worth $7.3M.

Question 2

How many shares of RLMD does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 1,061,665 shares of RLMD (Relmada Therapeutics).

Question 3

What is Citadel Advisors' RLMD position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' RLMD position is worth $7.3M.

Question 4

Is Citadel Advisors buying or selling RLMD?

Accepted Answer

In Q2 2026, Citadel Advisors opened a new RLMD position of 1,061,665 shares.

Question 5

When did Citadel Advisors first buy RLMD?

Accepted Answer

Citadel Advisors already held RLMD in its Q4 2019 13F, the earliest on record, and has listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	1.1M	-	$7.3M	0.0%	$6.92	38
2026-Q1	Exited	0	-100.0%	$0	0.0%	$4.67	0
2025-Q4	New	28,063	-	$135,544	0.0%	$4.53	34
2024-Q4	Exited	0	-100.0%	$0	0.0%	$0.46	0
2024-Q3	Decreased	52,846	-37.3%	$171,221	0.0%	$3.37	0

RLMDShowing 5 of 23 quarters

RLMD
Showing 5 of 23 quarters